Most people in the US are happy with their health insurance, but many still struggle with denied claims, delays and rising costs.

South Carolina health officials say a measles outbreak is growing amid holiday travel and low vaccination rates.

The US Food and Drug Administration is considering adding the strongest safety warning available to COVID-19 vaccines.

The FDA has approved Blujepa for the treatment of uncomplicated urogenital gonorrhea caused by susceptible strains of Neisseria gonorrhoeae.

Trauma severity predicted SSI risk and ertapenem prophylaxis reduced traumatic wound infection rates following exploratory laparotomy for visceral perforation.

COVID-19, RSV, and influenza immunizations show continued safety and substantial effectiveness against hospitalization across various populations.

Elevated lactate levels and hypotension independently predicted higher in-hospital mortality in critically ill adults with COVID-19.

A system-level, multifactorial intervention significantly reduced the risk of maternal infection outcomes, according to a recent study.

Ablation therapy demonstrated comparable effectiveness for HCC in patients with hepatitis B-related recompensated vs compensated cirrhosis.

The table below is a review of notable updates that occurred in November 2025 for investigational products in development (not an inclusive list). Click on the status ...